Home › Funds › Headland Capital, LLC › JNJ

Headland Capital, LLC position in JNJ

Johnson & Johnson · Health Care

Headland Capital, LLC reported holding 1,168 shares of JNJ (Johnson & Johnson) in its Q3 2026 13F filing — a position valued at US$309K, representing 0.08% of its reported portfolio and ranking #47 among its reported holdings. Headland Capital, LLC has disclosed JNJ holdings in 6 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)1.17K sh
Reported value held$309.17K
Portfolio Weight0.08%
First reportedQ1 2025
Last changeAdd
Updated2026-11-06

Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR

How Headland Capital, LLC's JNJ position evolved

Headland Capital, LLC first disclosed a stake in JNJ in Q1 2025 at 1,257 shares (US$208K). The position peaked in Q3 2026 at 1,168 shares, worth US$309K. Across 6 filings, Headland Capital, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,168 shares valued at US$309K — an increase of 10 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2025 1.26K $208.49K New
Q3 2025 1.27K $235.28K New
Q4 2025 1.17K $241.75K Reduce
Q1 2026 1.16K $283.06K Reduce
Q2 2026 1.16K $294.10K Hold
Q3 2026 1.17K $309.17K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (Johnson & Johnson) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Headland Capital, LLC held JNJ?

Headland Capital, LLC has disclosed JNJ holdings in 6 of the last 7 reported quarters, going back to Q1 2025.

What is Headland Capital, LLC's current position in JNJ?

As of Q3 2026, Headland Capital, LLC holds 1.17K shares of JNJ (Johnson & Johnson), valued at $309.17K, representing 0.08% of its reported portfolio and ranking #47.

Has Headland Capital, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Headland Capital, LLC increased its position in JNJ. The position peaked in Q3 2026 at 1.17K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.